Advertisement

Supportive Care in Cancer

, Volume 24, Issue 10, pp 4393–4398 | Cite as

Chamomile infusion cryotherapy to prevent oral mucositis induced by chemotherapy: a pilot study

  • Paula Elaine Diniz dos ReisEmail author
  • Marcia A. Ciol
  • Nilce Santos de Melo
  • Paulo Tadeu de Souza Figueiredo
  • André Ferreira Leite
  • Natália de Melo Manzi
Original Article

Abstract

Purpose

The aim of this study is to compare cryotherapy made only with water and cryotherapy made with chamomile infusion for prevention and reduction of intensity of oral mucositis in patients with cancer receiving 5-fluorouracil and leucovorin.

Method

This is a randomized pilot study with two groups: cryotherapy made only with water (control group, n = 18) and cryotherapy made with chamomile infusion (chamomile group, n = 20). Both groups were instructed to swish the ice around in their oral cavity for at least 30 min during chemotherapy. Assessment of oral mucosa occurred on days 8, 15, and 22 after the first day of chemotherapy.

Results

Fifty percent of the patients in the control and 30 % in the chamomile group developed oral mucositis. Mouth pain score was higher in patients in the control group on all evaluations (p = 0.02 for day 8, p = 0.09 for day 15, and p = 0.14 for day 22). Patients in the chamomile group never developed mucositis with grade 2 or higher. Presence of ulceration was statistically significant on day 8 (16 % in the control vs. 0 % in the chamomile group, p = 0.10), but not in days 15 and 22, although 11 % still had ulcerations in the control group and none in the chamomile group.

Conclusion

The occurrence of oral mucositis was lower in patients in the chamomile group than in the control group. When compared to the controls, the chamomile group presented less mouth pain and had no ulcerations. Cryotherapy was well tolerated by both groups, and no toxicity related to chamomile was identified.

Keywords

Oral care Cryotherapy Chemotherapy Cancer Oral mucositis 

Notes

Acknowledgments

We acknowledge the dentist Fábio Fernandes Alves for clinical evaluation of oral mucositis and the nurses Nayara Narley Pires Vieira, Karine Raphaela Missias da Silva, and Carlos de Jesus Sacramento for the intervention applied. We also acknowledge the National Committee for Research and Scientific Development (CNPQ), Brazil, for funding this study.

Compliance with ethical standards

Ethical considerations

Each patient provided written consent prior to starting the procedures. The study was approved by the Committee on Ethics Research of the School of Health Sciences of the University of Brasília.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Lalla RV, Bowen J, Barasch A et al (2014) MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer 120(10):1453–1461. doi: 10.1002/cncr.28592 CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Baydar M, Dikilitas M, Sevinc A, Aydogdu I (2005) Prevention of oral mucositis due to 5-fluorouracil treatment with oral cryotherapy. J Natl Med Assoc 97(8):1161–1164PubMedPubMedCentralGoogle Scholar
  3. 3.
    Jones JA, Avritscher EB, Cooksley CD, Michelet M, Bekele BN, Elting LS (2006) Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Support Care Cancer 14(6):505–515. doi: 10.1007/s00520-006-0055-4 CrossRefPubMedGoogle Scholar
  4. 4.
    Peterson DE, Bensadoun RJ, Roila F, ESMO Guidelines Working Group (2011) Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol 22(Suppl 6):vi78–84. doi: 10.1093/annonc/mdr391 PubMedPubMedCentralGoogle Scholar
  5. 5.
    Sorensen JB, Skovsgaard T, Bork E, Damstrup L, Ingeberg S (2008) Double-blind, placebo-controlled, randomized study of chlorhexidine prophylaxis for 5-fluorouracil-based chemotherapy-induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer 112(7):1600–1606. doi: 10.1002/cncr.23328 CrossRefPubMedGoogle Scholar
  6. 6.
    Katranci N, Ovayolu N, Ovayolu O, Sevinc A (2012) Evaluation of the effect of cryotherapy in preventing oral mucositis associated with chemotherapy—a randomized controlled trial. Eur J Oncol Nurs 16(4):339–344. doi: 10.1016/j.ejon.2011.07.008 CrossRefPubMedGoogle Scholar
  7. 7.
    Peterson DE, Ohrn K, Bowen J et al (2013) Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer 21(1):327–332. doi: 10.1007/s00520-012-1562-0 CrossRefPubMedGoogle Scholar
  8. 8.
    Manzi NM, Silveira RCCP, Reis PED (2015) Prophilaxis for mucositis induced by ambulatory chemotherapy: systematic review. J Adv Nurs 72(4):735–746. doi: 10.1111/jan.12867 CrossRefGoogle Scholar
  9. 9.
    Riley P, Glenny AM, Worthington HV, Littlewood A, Clarkson JE, McCabe MG (2015) Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy. Cochrane Database Syst Rev. doi: 10.1002/14651858 Google Scholar
  10. 10.
    Papadeas E, Naxakis S, Riga M, Kalofonos C (2007) Prevention of 5-fluorouracil-related stomatitis by oral cryotherapy: a randomized controlled study. Eur J Oncol Nurs 11(1):60–65. doi: 10.1016/j.ejon.2006.05.002 CrossRefPubMedGoogle Scholar
  11. 11.
    Logan RM, Gibson RJ, Sonis ST, Keefe DM (2007) Nuclear factor-kB (NF-kB) and cyclooxygenase-2 (COX-2) expression in the oral mucosa following cancer chemotherapy. Oral Oncol 43(4):395–401. doi: 10.1016/j.oraloncology.2006.04.011 CrossRefPubMedGoogle Scholar
  12. 12.
    Logan RM, Stringer AM, Bowen JM, Yeoh AS, Gibson RJ, Sonis ST, Keefe DM (2007) The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev 33(5):448–460. doi: 10.1016/j.ctrv.2007.03.001 CrossRefPubMedGoogle Scholar
  13. 13.
    Sonis ST (2010) New thoughts on the initiation of mucositis. Oral Dis 16(7):597–600. doi: 10.1111/.j.1601-0825.2010.01681.x CrossRefPubMedGoogle Scholar
  14. 14.
    Srivastava JK, Shankar E, Gupta S (2010) Chamomile: a herbal medicine of the past with a bright future. Mol Med Rep 3(6):895–901. doi: 10.3892/mmr.2010.377 PubMedPubMedCentralGoogle Scholar
  15. 15.
    Ferreira EB, Vasques CI, Jesus CAC, Reis PED (2015) Topical effects of Chamomilla recutita in skin damage: a literature review. Pharmacol Online 3:123–130Google Scholar
  16. 16.
    Fidler P, Loprinzi CL, O’Fallon JR, Leitch JM, Lee JK, Hayes DL, Novotny P, Clemens-Schutjer D, Bartel J, Michalak JC (1996) Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer 77(3):522–525CrossRefPubMedGoogle Scholar
  17. 17.
    Braga FTMM, Santos ACF, Bueno PCP, Silveira RCCP, Santos CB, Bastos JK, Carvalho EC (2015) Use of Chamomilla recutita in the prevention and treatment of oral mucositis in patients undergoing hematopoietic stem cell transplantation: a randomized, controlled, phase II clinical trial. Cancer Nurs 38(4):322–329. doi: 10.1097/NCC.0000000000000194 CrossRefPubMedGoogle Scholar
  18. 18.
    O’Connell MJ, Mailliard JA, Kahn MJ, Macdonald JS, Haller DG, Mayer RJ, Wieand HS (1997) Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer. J Clin Oncol 15(1):246–250PubMedGoogle Scholar
  19. 19.
    Reis PED, Carvalho EC, Bueno PCP, Bastos JK (2011) Clinical application of Chamomilla recutita in phlebitis: dose response curve study. Rev Lat Am Enfermagem 19(1):03–10. doi: 10.1590/S0104-11692011000100002 CrossRefGoogle Scholar
  20. 20.
    World Health Organization (1979) Handbook for reporting results of cancer treatment. Geneva, Switzerland. http://apps.who.int/iris/bitstream/10665/37200/1/WHO_OFFSET_48.pdf. Accessed 31 Jan 2016
  21. 21.
    Sendlbeck M, Araujo EG, Schett G, Englbrecht M (2015) Psychometric properties of three single-item pain scales in patients with rheumatoid arthritis seen during routine clinical care: a comparative perspective on construct validity, reproducibility and internal responsiveness. RMD Open 1(1), e000140. doi: 10.1136/rmdopen-2015-000140 CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Nikoletti S, Hyde S, Shaw T, Myers H, Kristjanson LJ (2005) Comparison of plain ice and flavoured ice for preventing oral mucositis associated with the use of 5 fluorouracil. J Clin Nurs 14(6):750–753. doi: 10.1111/j.1365-2702.2005.01156.x CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Paula Elaine Diniz dos Reis
    • 1
    Email author
  • Marcia A. Ciol
    • 2
  • Nilce Santos de Melo
    • 3
  • Paulo Tadeu de Souza Figueiredo
    • 3
  • André Ferreira Leite
    • 3
  • Natália de Melo Manzi
    • 4
  1. 1.Nursing Department, School of Health SciencesUniversity of BrasíliaBrasiliaBrazil
  2. 2.Department of Rehabilitation Medicine, School of MedicineUniversity of WashingtonSeattleUSA
  3. 3.Dentistry Department, School of Health SciencesUniversity of BrasíliaBrasíliaBrazil
  4. 4.Medical DepartmentSenado FederalBrasíliaBrazil

Personalised recommendations